UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care

External News Details

UCB, a global biopharmaceutical company with North America Operations headquarters inAtlanta, today announced a collaboration with the Georgia Institute of Technology's Interoperability and Integration Innovation Lab (I3L) to explore the potential of predictive analytics to help inform treatment decisions for people living with epilepsy.

Additional Information

Groups

IPaT

Categories
No categories were selected.
Keywords
No keywords were submitted.
Status
  • Created By: Bobby Macedonia
  • Workflow Status: Published
  • Created On: Feb 9, 2015 - 11:49am
  • Last Updated: Oct 7, 2016 - 10:23pm